Please enter exact key words
Available Projects

Dedicated to the discovery and development of new therapies to enhance living standard and health

Home / Available Projects
Available Projects

At Protheragen, we help out-license and find co-development opportunities for drug development programs. We aspire to play a role in transforming the scientific innovations into medications, helping patients with the most challenging diseases. Our main focus is on oncology programs. Most programs that are available on the list below are at preclinical stage with great therapeutic and market potential.

If you are interested in any of the projects, please contact us for further discussion. We look forward to our collaboration.

Program Indication Discovery Preclinical PhaseⅠ PhaseⅡ PhaseⅢ
Antibody Therapy
Antibody Product Portfolio Cancer
ANTIGN-109 Cancer
ANTICA-201 Cancer
CD3XCD20 bsAb Lymphomas
Cl3hmAb Acquired immune deficiency syndrome
Anti-MUC1-Ab Solid tumor
CD3xBCMA-bsAb Multiple myeloma
IGY-110 Covid-19
LAG3-Ab Cancer
OX40-Ab Cancer
Recombinant Protein Therapy
P75NEURO Neurological diseases
P11 Type 2 diabetes
Angiocidin Acute myeloid leukemia
TT-173 Surgical bleeding and trauma
Oncolytic Virotherapy
RV-scFv-PDL1 Cancer
OV-FV-01 Cancer
Small Molecules
Polyoxygenated Cyclohexene Compound 4 Pain
Fascin Inhibitor Cancer
Mitochondrial Uncoupling Agent Nonalcoholic steatohepatitis
HBV Capsid Inhibitor Hepatitis B
KCNQ2/3 Potassium Channel Opener Epilepsy
Resveratrol (Micellar) Alzheimer’s disease
Inflammatory factor regulators Psoriasis
NMMHC IIA Inhibitors Thrombosis
VISTA Agonist Psoriasis
Berbamine Analogues (+)ssRNA virus infections
Cell Therapy
Double Negative T Cells Acute myelocytic leukemia
Anti-BCMA CAR-T Cell Multiple myeloma
RNA Therapy
RNA4TNBC Triple-negative breast cancer

Protheragen’s business is growing rapidly after founded in Ronkonkoma, New York in 2009. More offices have been established at different locations across China and the US ever since.

Protheragen Inc.

2200 Smithtown Avenue, Room 1, Ronkonkoma,
NY 11779-7329, USA
Phone: 1-516-765-9461    Fax: 1-516-927-0118
Email: info@protheragen.com